Cargando…
A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome
OBJECTIVE: Ground-glass opacities are the most frequent radiologic features of COVID-19 patients. We aimed to determine the feasibility of automated lung volume measurements, including ground-glass volumes, on the CT of suspected COVID-19 patients. Our goal was to create an automated and quantitativ...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664353/ https://www.ncbi.nlm.nih.gov/pubmed/33197638 http://dx.doi.org/10.1016/j.accpm.2020.10.014 |
_version_ | 1783609827861200896 |
---|---|
author | Noll, Eric Soler, Luc Ohana, Mickael Ludes, Pierre-Olivier Pottecher, Julien Bennett-Guerrero, Elliott Veillon, Francis Goichot, Bernard Schneider, Francis Meyer, Nicolas Diemunsch, Pierre |
author_facet | Noll, Eric Soler, Luc Ohana, Mickael Ludes, Pierre-Olivier Pottecher, Julien Bennett-Guerrero, Elliott Veillon, Francis Goichot, Bernard Schneider, Francis Meyer, Nicolas Diemunsch, Pierre |
author_sort | Noll, Eric |
collection | PubMed |
description | OBJECTIVE: Ground-glass opacities are the most frequent radiologic features of COVID-19 patients. We aimed to determine the feasibility of automated lung volume measurements, including ground-glass volumes, on the CT of suspected COVID-19 patients. Our goal was to create an automated and quantitative measure of ground-glass opacities from lung CT images that could be used clinically for diagnosis, triage and research. DESIGN: Single centre, retrospective, observational study. MEASUREMENTS: Demographic data, respiratory support treatment (synthetised in the maximal respiratory severity score) and CT-images were collected. Volume of abnormal lung parenchyma was measured with conventional semi-automatic software and with a novel automated algorithm based on voxels X-Ray attenuation. We looked for the relationship between the automated and semi-automated evaluations. The association between the ground-glass opacities volume and the maximal respiratory severity score was assessed. MAIN RESULTS: Thirty-seven patients were included in the main outcome analysis. The mean duration of automated and semi-automated volume measurement process were 15 (2) and 93 (41) min, respectively (p = 8.05*10(−8)). The intraclass correlation coefficient between the semi-automated and automated measurement of ground-glass opacities and restricted normally aerated lung were both superior to 0.99. The association between the automated measured lung volume and the maximal clinical severity score was statistically significant for the restricted normally aerated (p = 0.0097, effect-size: −385 mL) volumes and for the ratio of ground-glass opacities/restricted normally aerated volumes (p = 0.027, effect-size: 3.3). CONCLUSION: The feasibility and preliminary validity of automated impaired lung volume measurements in a high-density COVID-19 cluster was confirmed by our results. |
format | Online Article Text |
id | pubmed-7664353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76643532020-11-16 A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome Noll, Eric Soler, Luc Ohana, Mickael Ludes, Pierre-Olivier Pottecher, Julien Bennett-Guerrero, Elliott Veillon, Francis Goichot, Bernard Schneider, Francis Meyer, Nicolas Diemunsch, Pierre Anaesth Crit Care Pain Med Original Article OBJECTIVE: Ground-glass opacities are the most frequent radiologic features of COVID-19 patients. We aimed to determine the feasibility of automated lung volume measurements, including ground-glass volumes, on the CT of suspected COVID-19 patients. Our goal was to create an automated and quantitative measure of ground-glass opacities from lung CT images that could be used clinically for diagnosis, triage and research. DESIGN: Single centre, retrospective, observational study. MEASUREMENTS: Demographic data, respiratory support treatment (synthetised in the maximal respiratory severity score) and CT-images were collected. Volume of abnormal lung parenchyma was measured with conventional semi-automatic software and with a novel automated algorithm based on voxels X-Ray attenuation. We looked for the relationship between the automated and semi-automated evaluations. The association between the ground-glass opacities volume and the maximal respiratory severity score was assessed. MAIN RESULTS: Thirty-seven patients were included in the main outcome analysis. The mean duration of automated and semi-automated volume measurement process were 15 (2) and 93 (41) min, respectively (p = 8.05*10(−8)). The intraclass correlation coefficient between the semi-automated and automated measurement of ground-glass opacities and restricted normally aerated lung were both superior to 0.99. The association between the automated measured lung volume and the maximal clinical severity score was statistically significant for the restricted normally aerated (p = 0.0097, effect-size: −385 mL) volumes and for the ratio of ground-glass opacities/restricted normally aerated volumes (p = 0.027, effect-size: 3.3). CONCLUSION: The feasibility and preliminary validity of automated impaired lung volume measurements in a high-density COVID-19 cluster was confirmed by our results. Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021-02 2020-11-13 /pmc/articles/PMC7664353/ /pubmed/33197638 http://dx.doi.org/10.1016/j.accpm.2020.10.014 Text en © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Noll, Eric Soler, Luc Ohana, Mickael Ludes, Pierre-Olivier Pottecher, Julien Bennett-Guerrero, Elliott Veillon, Francis Goichot, Bernard Schneider, Francis Meyer, Nicolas Diemunsch, Pierre A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title | A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title_full | A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title_fullStr | A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title_full_unstemmed | A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title_short | A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome |
title_sort | novel, automated, quantification of abnormal lung parenchyma in patients with covid-19 infection: initial description of feasibility and association with clinical outcome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664353/ https://www.ncbi.nlm.nih.gov/pubmed/33197638 http://dx.doi.org/10.1016/j.accpm.2020.10.014 |
work_keys_str_mv | AT nolleric anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT solerluc anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT ohanamickael anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT ludespierreolivier anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT pottecherjulien anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT bennettguerreroelliott anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT veillonfrancis anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT goichotbernard anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT schneiderfrancis anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT meyernicolas anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT diemunschpierre anovelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT nolleric novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT solerluc novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT ohanamickael novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT ludespierreolivier novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT pottecherjulien novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT bennettguerreroelliott novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT veillonfrancis novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT goichotbernard novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT schneiderfrancis novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT meyernicolas novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome AT diemunschpierre novelautomatedquantificationofabnormallungparenchymainpatientswithcovid19infectioninitialdescriptionoffeasibilityandassociationwithclinicaloutcome |